Cargando…
Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
Autores principales: | Yang, Yanbing, Ye, Xuenian, Zhang, Haibin, Lin, Zhaowang, Fang, Min, Wang, Jian, Yu, Yuyan, Hua, Xuwen, Huang, Hongxuan, Xu, Weifeng, Liu, Ling, Lin, Zhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928155/ https://www.ncbi.nlm.nih.gov/pubmed/36798531 http://dx.doi.org/10.3389/fgene.2023.1146199 |
Ejemplares similares
-
A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023) -
Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
por: Xu, Linfeng, et al.
Publicado: (2021) -
Corrigendum: Myometrial Transcriptional Signatures of Human Parturition
por: Stanfield, Zachary, et al.
Publicado: (2019) -
Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021) -
Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2021)